Clinical Trial Update: Determination of Salivary Soluble Urokinase Plasminogen Activator Receptor (SuPAR), Hypoxia-inducible Factor-1 Alpha (HIF-1α), E-cadherin, Galectin 3, IL-4, IL-10 and TNF-α Levels in Individuals With Different Degrees of Periodontal Disease

View source ↗

Summary

A university-sponsored clinical trial evaluating salivary biomarkers (SuPAR, HIF-1α, E-cadherin, Galectin-3, IL-4, IL-10, TNF-α) across different severities of …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Periodontal Disease
• Periodontitis

Snippet

Sponsor: Karamanoğlu Mehmetbey University | Conditions: Periodontitis, Periodontal Diseases | Status: NOT_YET_RECRUITING